Long-term outcome of the unrestricted use of everolimus-eluting stents compared to sirolimus-eluting stents and paclitaxel-eluting stents in diabetic patients: the Bern-Rotterdam diabetes cohort study.
about
Comparison of First- and Second-Generation Drug-Eluting Stents in an All-Comer Population of Patients with Diabetes Mellitus (from Katowice-Zabrze Registry).Stent thrombosis and adverse cardiovascular outcomes observed between six months and five years with sirolimus-eluting stents and other drug-eluting stents in patients with Type 2 diabetes mellitus complicated by coronary artery disease: A systematiEvolution of coronary stents in patients with diabetes: are clinical outcomes still improving?Third generation drug eluting stent (DES) with biodegradable polymer in diabetic patients: 5 years follow-up.Long-term outcome of early percutaneous coronary intervention in diabetic patients with acute coronary syndrome: insights from the BASE ACS trial.Impact of diabetes on the benefits from everolimus-eluting stent as compared to first-generation drug-eluting stent in patients with ST elevation myocardial infarction.Second vs. First generation drug eluting stents in multiple vessel disease and left main stenosis: Two-year follow-up of the observational, prospective, controlled, and multicenter ERACI IV registry.Rationale and study design of the RESERVOIR trial: a randomized trial comparing reservoir-based polymer-free amphilimus-eluting stents versus everolimus-eluting stents with durable polymer in patients with diabetes mellitus.Cardiac Versus Non-Cardiac Related Mortality Following Percutaneous Coronary Intervention in Patients with Insulin-Treated Type 2 Diabetes Mellitus: A Meta-Analysis.Early (≤ 30 Days), Late (31-360 Days) and Very Late (> 360 Days) Stent Thrombosis in Patients with Insulin-Treated versus Non-Insulin-Treated Type 2 Diabetes Mellitus: A Meta-Analysis.
P2860
Q36239147-896D3366-2D85-42CB-AF4B-26A4B97F3853Q37328131-1F31ED4C-AE8E-4275-8C4A-5A7FF117AB76Q38221101-91115A0D-340D-4541-823B-A0ED2FEF0B4AQ38969182-E633272C-DC77-4F0D-9B7D-29D5AD3496ACQ39727135-05C98471-DC88-4808-B8D6-D78E2962A196Q40762800-3F8AC1C1-8298-4197-8EFF-4DEABC393A51Q40869603-DC98ABB5-C8B3-47D7-A2C5-AA43B3D5509BQ53395463-382768F5-3CF9-4990-B0A3-DFA1120F2EEDQ55064768-5CED38C6-F99F-43AD-8E7B-75602FB182D2Q55304172-03854389-F7F2-4217-8DBA-211FD5470925
P2860
Long-term outcome of the unrestricted use of everolimus-eluting stents compared to sirolimus-eluting stents and paclitaxel-eluting stents in diabetic patients: the Bern-Rotterdam diabetes cohort study.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh-hant
name
Long-term outcome of the unres ...... tterdam diabetes cohort study.
@en
Long-term outcome of the unres ...... tterdam diabetes cohort study.
@nl
type
label
Long-term outcome of the unres ...... tterdam diabetes cohort study.
@en
Long-term outcome of the unres ...... tterdam diabetes cohort study.
@nl
prefLabel
Long-term outcome of the unres ...... tterdam diabetes cohort study.
@en
Long-term outcome of the unres ...... tterdam diabetes cohort study.
@nl
P2093
P1476
Long-term outcome of the unres ...... tterdam diabetes cohort study.
@en
P2093
P W J C Serruys
P Wenaweser
R J van Geuns
R T van Domburg
S Windecker
P356
10.1016/J.IJCARD.2013.10.006
P407
P577
2013-10-12T00:00:00Z